RECK and neoplasm: Quantification of the immunoblot results demonstrates a statistically significant increase in RECK expression and reduction of MMP14 in rTIMP2 treated wt tumor-bearing mice compared with vehicle control (HBSS) treated wt tumor-bearing mice.